- 1. 908
- [The calcium salt form of fosamprenavir, prodrug of amprenavir, and a human immunodeficiency virus (HIV) protease inhibitor with antiviral property. Fosamprenavir is converted to amprenavir by cellular phosphatases in the epithelial cells of the intestine. Then amprenavir binds to the active site of HIV-1 protease, thereby preventing the proteolytic cleavage of viral Gag-Pol polypeptide into individual functional proteins, thereby leading to the formation of immature non-infectious viral particles. ( NCI )] (UMLS (NCI) C1321660) Fosamprenavir Calcium =Organophosphorus Compound; Pharmacologic Substance
| - 51. Calcium Gluconate/Cholecalciferol/Zoledronate
- (UMLS (NCI) C1134455) =Therapeutic or Preventive Procedure ;
|
- 2. Calan
- (UMLS (NCI) C0700935) =Organic Chemical; Pharmacologic Substance ;
| - 52. calcium indicator
- [nontoxic dyes or fluors which undergo spectral changes upon calcium ion binding and can be loaded into cells to visualize calcium fluxes. ( CSP )] (UMLS (CSP) C0596234) =Indicator, Reagent, or Diagnostic Aid =reagent/indicator;
|
- 3. calbindin
- [vitamin D dependent calcium binding protein; may act as an intracellular calcium buffer. ( CSP )] (UMLS (CSP) C0054444) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=calcium binding protein;
| - 53. CALCIUM ION
- [The metabolically-active portion of calcium, not bound to proteins, circulating in the blood. ( NCI )] (UMLS (NCI) C0596235) =Element, Ion, or Isotope =ion;
|
- 4. CALCA
- [This gene is involved in the regulation of bone incorporation and blood calcium and phosphate levels. ( NCI )] (UMLS (NCI) C1367551) CALCA Gene;
Calcitonin/Calcitonin-Related Polypeptide, Alpha Gene =Gene or Genome | - 54. Calcium Ion Signaling
- [Triggered by external stimuli, Calcium Signaling involves local influx, or mobilization from the ER through IP3R and RyR channels, of calcium ions into the cytoplasm as an intracellular second messenger in mechanisms that activate calcium-responsive signal transduction proteins that regulate diverse forms of cellular activity. ( NCI )] (UMLS (NCI) C0600431) =Cell Function
|
- 5. CALCANEAL SPUR
- [A bony outgrowth on the lower surface of the CALCANEUS. Though often presenting along with plantar fasciitis (FASCIITIS, PLANTAR), they are not considered causally related. ( MSH )] (UMLS (ICD9CM) C0158322) =Disease or Syndrome
| - 55. calcium metabolism
- [sum of chemical changes that occur within the tissues of an organism consisting of anabolism (biosynthesis) and catabolism of calcium; the buildup and breakdown of calcium for utilization by the organism. ( CSP )] (UMLS (CSP) C0596236) =Organism Function =electrolyte balance;
metal metabolism =calcification;
|
- 6. Calcaneofibular (ligament) ankle sprain
- [ ] (UMLS (ICD9CM) C0160090) =Injury or Poisoning
| - 56. calcium metabolism disorder
- [Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization. ( MSH )] (UMLS (CSP) C0006705) =Disease or Syndrome =Metabolic Disease;
=Calcinosis;
Decalcification, Pathologic;
hypercalcemia;
hypocalcemia;
osteomalacia;
Albright's hereditary osteodystrophy;
rickets |
- 7. Calcaneum
- [The largest of the TARSAL BONES which is situated at the lower and back part of the FOOT, forming the HEEL. ( MSH )] (UMLS (NCI) C0006655) =Body Part, Organ, or Organ Component
| - 57. Calcium Modulating Ligand
- [Calcium Modulating Ligand (CAMLG), encoded by the CAMLG gene, blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. CAML binds and inactivates the key signaling intermediate calcineurin, downstream of the TCR and upstream of calcineurin, by causing an influx of calcium. This integral membrane protein may be a new participant in the calcium signal transduction pathway and implicates cyclophilin B in calcium signaling. CAML regulates calcium signaling in T lymphocytes and other cells. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C1260021) Calcium-Modulating Cyclophilin Ligand;
Calcium-Signal Modulating Cyclophilin Ligand;
CAMLG;
Cyclophilin B-Binding Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 8. CALCANEUS DEFORMITY NEC
- [ ] (UMLS (ICD9CM) C0158494) =Acquired Abnormality ;
| - 58. Calcium Modulating Ligand Gene
- [This gene plays a role in the regulation of calcium signaling to T lymphocytes and other cells. ( NCI )] (UMLS (NCI) C1332660) CAMLG;
CAMLG Gene =Gene or Genome ;
|
- 9. Calcarine Artery
- (UMLS (NCI) C0226253) =Body Part, Organ, or Organ Component
| - 59. calcium phosphate
- [calcium salts containing the phosphate radical (PO4), frequently used as calcium supplements. ( CSP )] (UMLS (CSP) C0006711) =Pharmacologic Substance; Inorganic Chemical ;
=[TN402] CALCIUM;
Calcium Phosphates;
Mineral;
phosphate =apatite;
CALCIUM (AS PHOSPHATE,DIBASIC);
CALCIUM PHOSPHATE,TRIBASIC;
CALCIUM PHOSPHATE,ANHYDROUS;
CALCIUM (AS PHOSPHATE,DIBASIC);
CALCIUM PHOSPHATE,TRIBASIC;
MERITENE POWDER (CHOCOLATE);
MERITENE POWDER (MILK CHOCOLATE);
MERITENE POWDER (PLAIN);
MERITENE POWDER (VANILLA);
ISOTEIN HN POWDER;
LACTASE 3000 U Oral (systemic) tablet;
LONALAC POWDER,ORAL;
MERITENE POWDER (EGG NOG);
ULTRACAL TUBE-FEEDING LIQUID;
CALCIUM PHOSPHATE,ANHYDROUS;
|
- 10. Calcarine Sulcus
- (UMLS (NCI) C0228224) =Body Space or Junction
| - 60. Calcium Polycarbophil
- [A loosely cross-linked synthetic polycarboxylic-type hydrophilic polymer resin, laxative and anti-diarrheal Calcium Polycarbophil increases stool frequency, fecal water content, and fecal weight in a dose-dependent manner. It is used for idiopathic constipation, secretory diarrhea, and irritable bowel syndrome. (NCI04) ( NCI )] (UMLS (NCI) C0054480) =Organic Chemical; Pharmacologic Substance ;
=Acrylic Resins;
Calcium Polycarbophil;
[GA201] BULK-FORMING LAXATIVES;
TO BE DELETED INGREDIENT PREPARATIONS =CALCIUM POLYCARBOPHIL 625 MG;
LUBRICANT MOISTURIZER VAG,GEL,APPLICATOR,5.9GM;
Calcium Polycarbophil;
CALCIUM POLYCARBOPHIL 1 GM;
CALCIUM POLYCARBOPHIL 625 MG |
- 11. CALCER CORNEA DEGEN NEC
- [ ] (UMLS (ICD9CM) C0155121) =Acquired Abnormality; Disease or Syndrome
| - 61. calcium pyrophosphate dihydrate crystal deposition disease
- [Presence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0553730) =Disease or Syndrome =arthritis;
|
- 12. CALCIF TENDINITIS SHLDER
- [ ] (UMLS (ICD9CM) C0158303) =Disease or Syndrome ;
| - 62. Calcium Saccharate
- (UMLS (NCI) C0771997) =Organic Chemical; Pharmacologic Substance ;
|
- 13. calcification
- [process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. ( CSP )] (UMLS (CSP) C0006660) =Organ or Tissue Function ;
=calcium metabolism;
| - 63. Calcium Sulfate Anhydrous
- (UMLS (NCI) C0205691) =Biomedical or Dental Material; Inorganic Chemical
|
- 14. Calcification and ossification, unspecified
- [ ] (UMLS (ICD9CM) C0158355) =Disease or Syndrome
| - 64. Calcium Sulfate Dihydrate
- (UMLS (NCI) C0205692) =Biomedical or Dental Material; Inorganic Chemical
|
- 15. calcification inhibitor
- [substance or state which suppresses, prevents or opposes the deposit of calcium salt in organic tissues or calcification. ( CSP )] (UMLS (CSP) C0596231) =Pharmacologic Substance =inhibitor/antagonist;
=EHDP;
| - 65. Calcium-Activated Chloride Channel-2
- [Encoded by human CLCA2 Gene (similar to CLCA1), the 943-amino acid Calcium-Activated Chloride Channel-2 (CLCA Family) is expressed in trachea, lung, and mammary gland and displays outward rectifying anion conductance. Family members differ in tissue distribution. CLCA2 protein contains a large N-terminal extracellular domain containing conserved cysteines, five transmembrane domains, a monobasic proteolytic cleavage consensus site, potential glycosylation sites, and potential PKC phosphorylation sites. Nascent CLCA2 may be cleaved into 86 kD N-terminal, and 34 kD C-terminal, polypeptides associated with the cell surface. CLCA2 may play a role in the pathogenesis of cystic fibrosis and in cancer metastasis to the lung, mediating vascular arrest and colonization. CLCA2 has been implicated as a tumor suppressor for breast cancer. (from SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1332834) Calcium-Sensitive Chloride Channel 2;
Chloride Channel, Calcium Activated, Family Member 2 Protein;
CLCA2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 16. calcification stimulant
- [agent which potentiates or enhances the deposition of calcium salts in tissue. ( CSP )] (UMLS (CSP) C0596232) =Pharmacologic Substance =stimulant/agonist;
| - 66. Calcium-Binding Protein ERC55
- [Encoded by human RCN2 Gene (CREC Family), ubiquitous 317-aa 55-kD calcium-binding Reticulocalbin 2 contains 6 conserved helix-loop-helix EF-hand calcium-binding domains and a C-terminal HDEL sequence required for ER retention. RCN2 appears to interact with human papillomavirus transforming protein E6 and with the vitamin D receptor. (NCI) ( NCI )] (UMLS (NCI) C1335763) E6-Binding Protein;
E6BP;
Endoplasmic Reticulum Calcium-Binding Protein 55kD;
RCN2;
Reticulocalbin 2 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 17. Calcified
- [Having calcium deposited on or in an anatomic structure. ( NCI )] (UMLS (NCI) C0175895) =Pathologic Function
| - 67. Calcium-Independent Cytosolic Phospholipase A2 Group IVC
- [Expressed (3-kb mRNA) in skeletal muscle, heart, and other tissues by human PLA2G4C Gene, 541-aa Cytosolic Phospholipase A2G4C is a calcium-independent membrane-associated prenylated phospholipase with 28% amino acid sequence identity to cPLA2-Alpha that catalyzes (cleaving at sn-1 or sn-2 sites) release of arachidonate from phospholipids. (NCI) ( NCI )] (UMLS (NCI) C0757021) Calcium-Independent Cytosolic Phospholipase A2 IVC;
cPLA2-Gamma;
Cytosolic Phospholipase A2 Gamma;
Cytosolic Phospholipase A2 IVC;
Cytosolic Phospholipase A2G4C;
Phospholipase A2 Group IVC;
Phospholipase A2IVC;
PLA2G4C =Amino Acid, Peptide, or Protein; Enzyme |
- 18. Calcifying Aponeurotic Fibroma
- [A rare slow-growing benign neoplasm arising from the soft tissues in children. It is a poorly circumscribed tumor characterized by the presence of chondrocyte-like cells, nodular calcification, nuclear palisading, and in some cases osteoclastic giant cells. ( NCI )] (UMLS (NCI) C0553647) =Neoplastic Process
| - 68. Calcofluor white fluorescent stain
- [Stain, Calcofluor white fluorescent ( HL7V3.0 )] (UMLS (HL7) C0200971) =Laboratory Procedure =ObservationMethod;
|
- 19. Calcifying Cystic Odontogenic Tumor
- [A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. (Stedman, 25th ed) ( MSH )] (UMLS (NCI) C0206740) =Neoplastic Process =DEVEL ODONTOGENIC CYSTS;
Odontogenic Neoplasm | - 69. Calculated observations master file
- (UMLS (HL7) C1549586) =Intellectual Product =Master file identifier code;
|
- 20. Calcifying Epithelial Odontogenic Tumor
- (UMLS (NCI) C0334574) =Neoplastic Process
| - 70. calculi (biliary)
- [Solid crystalline precipitates in the BILIARY TRACT, usually formed in the GALLBLADDER, resulting in the condition of CHOLELITHIASIS. Gallstones, derived from the BILE, consist mainly of calcium, cholesterol, or bilirubin. ( MSH )] (UMLS (CSP) C0242216) =Body Substance ;
|
- 21. Calcifying Fibrous Pseudotumor
- [A benign well-circumscribed paucicellular neoplasm arising from the soft tissues. It is characterized by the presence of fibroblasts, lymphoplasmacytic infiltrates, collagenous stroma formation, psammoma bodies, and dystrophic calcifications. ( NCI )] (UMLS (NCI) C1332833) Calcifying Fibrous Tumor;
=Neoplastic Process ;
| - 71. calculi (dental)
- [Mineralized deposit that forms on the teeth or dental prostheses. ( NCI )] (UMLS (CSP) C0011330) =Disease or Syndrome ;
=Calculi;
ACCRETIONS ON TEETH |
- 22. Calcijex
- (UMLS (NCI) C0591213) =Steroid; Pharmacologic Substance ;
| - 72. calculi dissolving agent
- [ ] (UMLS (CSP) C0598041) =Pharmacologic Substance ;
|
- 23. calcineurin
- [nonEC; calcium-calmodulin dependent protein phosphatase found in nerve cells and involved in intracellular signal transduction between the calcium and protein phosphorylation pathways. ( CSP )] (UMLS (CSP) C0054450) =Amino Acid, Peptide, or Protein; Enzyme ;
=phosphatase;
nerve/myelin protein | - 73. Calculus (=Stone)
- (UMLS (HL7) C1546570) =Intellectual Product =Specimen Source Codes;
|
- 24. Calcipotriene
- [A synthetic vitamin D derivative usually formulated for topical dermatological use, antipsoriatic Calcipotriene (calcipotriol) competes equally with active 1,25-hydroxy-2D3 (the natural form of vitamin D) for 1,25-hydroxy-2D3 receptors in regulating cell proliferation and differentiation. It induces differentiation and suppresses proliferation of keratinocytes, reversing abnormal keratinocyte changes in psoriasis, and leads to normalization of epidermal growth. (NCI04) ( NCI )] (UMLS (NCI) C0065767) =Organic Chemical; Pharmacologic Substance =(1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol;
[DE802] ANTIPSORIATICS, TOPICAL =CALCIPOTRIENE 0.005 %;
| - 74. Calculus (=Stone)
- (UMLS (HL7) C1550620) Stone (use CALC);
=Body Substance =SpecimenEntityType;
|
- 25. calcitonin
- [a peptide hormone secreted by the parafollicular cells of the thyroid gland in response to hypercalcemia, which lowers blood calcium and phosphate by promoting renal excretion; chemotherapy for Paget's disease and severe hypercalcemia. ( CSP )] (UMLS (CSP) C0006668) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone ;
=neuropeptide;
Peptides;
Peptide Hormone;
[HS900] HORMONES/SYNTHETICS/MODIFIERS, OTHER =CALCITONIN, SALMON;
| - 75. Calculus in urethra
- [ ] (UMLS (ICD9CM) C0162301) =Disease or Syndrome
|
- 26. Calcitonin
- [Encoded by human CALCA Gene (Calcitonin Family), 32-aa 3.4-kD secreted Calcitonin polypeptide hormone is cleaved from a large polyprotein precursor synthesized by thyroid parafollicular 'C' cells. Opposite to the effect of PTH, Calcitonin induces a rapid drop in blood calcium and phosphate level by promoting bone incorporation. (NCI) ( NCI )] (UMLS (NCI) C0770558) Human calcitonin;
Thyrocalcitonin =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone | - 76. Calculus of bile duct with acute cholecystitis
- [ ] (UMLS (ICD9CM) C0156206) =Disease or Syndrome
|
- 27. calcitonin gene related peptide
- [37 residue neuropeptide expressed by the gene for calcitonin in neural (as opposed to thyroid) tissue; also inhibits insulin release and promotes amylase release by pancrease. ( CSP )] (UMLS (CSP) C0006669) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine; Hormone ;
=neuropeptide;
| - 77. Calculus of bile duct with acute cholecystitis without mention of obstruction
- [ ] (UMLS (ICD9CM) C0156207) =Disease or Syndrome
|
- 28. CALCITONIN, SALMON
- (UMLS (NCI) C0073994) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =calcitonin;
=CALCITONIN,SALMON 200 UNT/ACTUAT;
CALCITONIN,SALMON 200 UNT/ML;
| - 78. Calculus of bile duct with acute cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0156208) =Disease or Syndrome
|
- 29. Calcitriol/Carboplatin
- (UMLS (NCI) C0935755) =Therapeutic or Preventive Procedure
| - 79. Calculus of bile duct with other cholecystitis
- [ ] (UMLS (ICD9CM) C0156209) =Disease or Syndrome
|
- 30. Calcitriol/Dexamethasone
- (UMLS (NCI) C0935786) =Therapeutic or Preventive Procedure ;
| - 80. Calculus of bile duct with other cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0156211) =Disease or Syndrome
|
- 31. Calcitriol/Paclitaxel
- (UMLS (NCI) C0935782) =Therapeutic or Preventive Procedure ;
| - 81. Calculus of bile duct with other cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0156210) =Disease or Syndrome
|
- 32. Calcitriol/Zoledronate
- (UMLS (NCI) C1327735) =Therapeutic or Preventive Procedure
| - 82. Calculus of bile duct without mention of cholecystitis
- (UMLS (ICD9CM) C0006739) =Disease or Syndrome
|
- 33. Calcium (6S)-Folinate
- [An active metabolite of folic acid (also called folinic acid and citrovorum factor), which does not require metabolism by dihydrofolate reductase, the molecular target of folate antagonist-type chemotherapeutic drugs. Leucovorin calcium counteracts the toxic effects of these medications, 'rescuing' the patient while permitting the antitumor activity of the folate antagonist. This agent also potentiates the effects of fluorouracil and its derivatives by stabilizing the binding of the drug's metabolite to its target enzyme, thus prolonging drug activity. (NCI04) ( NCI )] (UMLS (NCI) C0731033) Calcium Folinate;
Calcium Leucovorin;
Calcium levoleucovorin;
Citrovorum Factor;
Factor, Citrovorum;
Folinate Calcium;
Folinic Acid Calcium Salt Pentahydrate;
LEUCOVORIN CALCIUM;
LEUCOVORIN CALCIUM PREPARATION;
Levofolinate calcium =Organic Chemical; Pharmacologic Substance; Vitamin =5-Formyl-5,6,7,8-tetrahydrofolic Acid;
=LEUCOVORIN CALCIUM 200 MG;
LEUCOVORIN CALCIUM 50 MG;
LEUCOVORIN CALCIUM 100 MG;
LEUCOVORIN CALCIUM 10 MG;
LEUCOVORIN CALCIUM 15 MG;
LEUCOVORIN CALCIUM 25 MG;
LEUCOVORIN CALCIUM 5 MG;
LEUCOVORIN CALCIUM 5 MG/ML;
LEUCOVORIN CALCIUM 350 MG;
LEUCOVORIN CALCIUM 3 MG/ML | - 83. Calculus of bile duct without mention of cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0489966) =Body Substance ;
|
- 34. calcium binding protein
- [proteins which bind calcium ions; can act as transport proteins, regulator proteins, or activator proteins. ( CSP )] (UMLS (CSP) C0006732) =Amino Acid, Peptide, or Protein; Receptor ;
=binding protein;
=calmodulin;
osteocalcin;
troponin;
calbindin;
calreticulin;
calretinin;
annexin;
phospholamban;
synaptotagmin;
calnexin;
| - 84. Calculus of bile duct without mention of cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0156212) =Disease or Syndrome
|
- 35. calcium binding troponin C
- [One of the three polypeptide chains that make up the TROPONIN complex of skeletal muscle. It is a calcium-binding protein. ( MSH )] (UMLS (CSP) C0077400) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 85. Calculus of gallbladder and bile duct with acute and chronic cholecystitis
- [ ] (UMLS (ICD9CM) C0375371) =Disease or Syndrome; Anatomical Abnormality
|
- 36. Calcium Carbonate/Cholecalciferol/Conjugated Estrogens
- (UMLS (NCI) C1327747) =Therapeutic or Preventive Procedure ;
| - 86. Calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0375373) =Disease or Syndrome; Anatomical Abnormality
|
- 37. Calcium Carbonate/Cholecalciferol/Conjugated Estrogens/Risedronate
- (UMLS (NCI) C1327748) =Therapeutic or Preventive Procedure ;
| - 87. Calculus of gallbladder and bile duct with acute and chronic cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0375372) =Disease or Syndrome; Anatomical Abnormality
|
- 38. Calcium Carbonate/Cholecalciferol/Risedronate
- (UMLS (NCI) C1327746) =Therapeutic or Preventive Procedure ;
| - 88. Calculus of gallbladder and bile duct with acute cholecystitis
- [ ] (UMLS (ICD9CM) C0375365) =Disease or Syndrome; Anatomical Abnormality
|
- 39. Calcium Carbonate/Cholecalciferol/Zoledronate
- (UMLS (NCI) C1134457) =Therapeutic or Preventive Procedure ;
| - 89. Calculus of gallbladder and bile duct with acute cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0375367) =Disease or Syndrome; Anatomical Abnormality
|
- 40. calcium channel
- [voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. ( CSP )] (UMLS (CSP) C0006685) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Ion Channel;
=PCP receptor;
N methyl D aspartate receptor | - 90. Calculus of gallbladder and bile duct with acute cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0375366) =Disease or Syndrome; Anatomical Abnormality
|
- 41. CALCIUM CHLORIDE
- [A crystalline, white substance, soluble in water, Calcium Chloride is the chloride salt of calcium, a bivalent metallic element with many crucial biological roles. Calcium is a major constituent of the skeleton but plays many roles as an intracellular and plasma ion as well. In medicine, calcium chloride is also used as a 10% solution in injection, for calcium replenishment. (NCI04) ( NCI )] (UMLS (NCI) C0006686) =Pharmacologic Substance; Inorganic Chemical =[TN402] CALCIUM;
Chlorides;
Calcium Compounds;
=CALCIUM CHLORIDE DIHYDRATE;
LONALAC POWDER,ORAL;
CALCIUM CHLORIDE 100 MG/ML;
Calcium Chloride 0.4 MG/ML;
Calcium Chloride 0.2 MG/ML;
CALCIUM CHLORIDE 0.004 GM/100ML;
CALCIUM CHLORIDE 0.02 GM;
CALCIUM CHLORIDE 0.029 GM;
CALCIUM CHLORIDE 0.029 GM/100ML;
CALCIUM CHLORIDE 0.048 %;
CALCIUM CHLORIDE 0.37 GM;
CALCIUM CHLORIDE 0.52 GM/100ML;
CALCIUM CHLORIDE 10 MG/100ML;
CALCIUM CHLORIDE 14.7 MG;
CALCIUM CHLORIDE 16.5 MG;
CALCIUM CHLORIDE 17.6 MG;
CALCIUM CHLORIDE 25.5 MG/100ML;
CALCIUM CHLORIDE 25.7 MG/100ML;
CALCIUM CHLORIDE 26 MG/100ML;
CALCIUM CHLORIDE 29 MG/100ML;
CALCIUM CHLORIDE 33 MG/100ML;
CALCIUM CHLORIDE 34 MG/100ML;
CALCIUM CHLORIDE 35 MG/100ML;
CALCIUM CHLORIDE 36.8 MG/100ML;
CALCIUM CHLORIDE 37 MG;
CALCIUM CHLORIDE 37 MG/100ML;
CALCIUM CHLORIDE 510 MG/100ML;
CALCIUM CHLORIDE 515 MG/100ML;
| - 91. Calculus of gallbladder and bile duct with other cholecystitis
- [ ] (UMLS (ICD9CM) C0375368) =Disease or Syndrome; Anatomical Abnormality
|
- 42. Calcium Chromate
- [A yellowish, crystalline, inorganic compound that emits toxic chromium fumes upon heating. Calcium chromate is highly corrosive and is a strong oxidizing agent. This substance is mainly used as a corrosion inhibitor and as a depolarizer in batteries. Calcium chromate primarily affects the nose, throat and lungs causing ulcerations, shortness of breath, bronchitis, pneumonia and asthma-like allergy but can also affect the gastrointestinal tract, liver, kidneys and immune system. This substance is a known human carcinogen and is associated with an increased risk of developing lung cancer and cancer of the sinonasal cavity. (NCI05) ( NCI )] (UMLS (NCI) C0054469) =Hazardous or Poisonous Substance; Inorganic Chemical ;
| - 92. Calculus of gallbladder and bile duct with other cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0375370) =Disease or Syndrome; Anatomical Abnormality
|
- 43. Calcium Citrate/Cholecalciferol
- (UMLS (NCI) C1134453) =Therapeutic or Preventive Procedure ;
| - 93. Calculus of gallbladder and bile duct with other cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0375369) =Disease or Syndrome; Anatomical Abnormality
|
- 44. Calcium Citrate/Cholecalciferol/Zoledronate
- (UMLS (NCI) C1134456) =Therapeutic or Preventive Procedure ;
| - 94. Calculus of gallbladder and bile duct without cholecystitis
- [ ] (UMLS (ICD9CM) C0375374) =Disease or Syndrome; Anatomical Abnormality
|
- 45. Calcium D-gluconate
- [The gluconate salt of calcium. An element or mineral necessary for normal nerve, muscle, and cardiac function, calcium as the gluconate salt helps to maintain calcium balance and prevent bone loss when taken orally. This agent may also be chemopreventive for colon and other cancers. (NCI04) ( NCI )] (UMLS (NCI) C0006699) =Organic Chemical; Pharmacologic Substance ;
=[TN402] CALCIUM;
gluconate =CALCIUM GLUCONATE MISC. POWDER (GM);
CRITICARE HN LIQUID;
CALCIUM GLUCONATE 100 MG/ML;
CALCIUM GLUCONATE 60 MG;
CALCIUM GLUCONATE 130 MG;
CALCIUM GLUCONATE 65 MG;
CALCIUM GLUCONATE 500 MG;
CALCIUM GLUCONATE 650 MG;
CALCIUM GLUCONATE 1 GM;
CALCIUM GLUCONATE 975 MG;
CALCIUM GLUCONATE 1.03 GM;
CALCIUM GLUCONATE 108 MG/100ML;
CALCIUM GLUCONATE 20.6 MG;
CALCIUM GLUCONATE 21.6 MG;
CALCIUM GLUCONATE 240 MG;
CALCIUM GLUCONATE 487.5 MG;
| - 95. Calculus of gallbladder and bile duct without cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0375376) =Disease or Syndrome; Anatomical Abnormality
|
- 46. CALCIUM DEPOSIT TENDON
- (UMLS (ICD9CM) C0006690) =Acquired Abnormality; Disease or Syndrome
| - 96. Calculus of gallbladder and bile duct without cholecystitis, without mention of obstruction
- [ ] (UMLS (ICD9CM) C0375375) =Disease or Syndrome; Anatomical Abnormality
|
- 47. Calcium Disodium Versenate
- (UMLS (NCI) C0701375) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 97. Calculus of gallbladder with acute cholecystitis
- [ ] (UMLS (ICD9CM) C0156199) =Disease or Syndrome
|
- 48. calcium disorder
- [condition in which there is a deviation or interruption in the processing of calcium in the body, its absorption, transport, storage, and utilization. ( CSP )] (UMLS (CSP) C0302590) =Pathologic Function =Disease;
=hypercalcemia;
hypercalcinuria;
hypocalcemia;
nephrocalcinosis;
osteomalacia;
pseudogout;
Albright's hereditary osteodystrophy;
rickets;
avanim bedarxe hasheten kolel klayot | - 98. Calculus of gallbladder with acute cholecystitis, with obstruction
- [ ] (UMLS (ICD9CM) C0156201) =Disease or Syndrome
|
- 49. calcium flux
- [large scale movement of calcium ions at the cellular level, as across the cell membrane, between organelles, or through the cytoplasm; a fundamental cellular signal transduction mechanism; do not confuse with CALCIUM METABOLISM, which applies to bodily balance. ( CSP )] (UMLS (CSP) C0596233) =Cell Function =Signal Transduction;
| - 99. Calculus of gallbladder with acute cholecystitis, without mention of obstruction
- (UMLS (ICD9CM) C0400985) =Disease or Syndrome ;
|
- 50. Calcium Gluconate/Cholecalciferol
- (UMLS (NCI) C1134454) =Therapeutic or Preventive Procedure ;
| - 100. Calculus of gallbladder with other cholecystitis
- [ ] (UMLS (ICD9CM) C0156202) =Disease or Syndrome
|
home
